- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02657070
Counteracting Learned Non-use Through Augmented Visuomotor Feedback in Virtual Reality (RGS)
January 14, 2016 updated by: Paul Verschure, Universitat Pompeu Fabra
Desaprendiendo la parálisis Aprendida Con RGS en Pacientes Afectos de Ictus
The purpose of this study is to determine if Reinforcement-Induced Movement Therapy (RIMT), a novel rehabilitation method that augments visuomotor feedback of movements of the patient in virtual reality, is effective in treating hemiparesis resp.
learned non-use.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Mild-to-moderate upper-limbs hemiparesis (Proximal Medical Research Council Scale > 2) due to ischemic or hemorrhagic stroke
- Spasticity in the affected limb (Modified Ashworth Scale <3)
- First-ever ischemic or hemorrhagic stroke (>4 weeks post-stroke)
- Sufficient cognitive capacity for following the instruction of the intervention (Mini-Mental State Evaluation >24)
Exclusion Criteria:
- Cognitive impairment that impede the correct execution or understanding of the intervention
- Severe impairments in vision or visual perception abilities (such as vision loss or spatial neglect), in spasticity, in communication abilities (such as aphasia or apraxia), severe pain as well as other neuromuscular or orthopedic changes that impede the correct execution of the intervention training
- Mental dysfunctioning during the acute or subacute phase after the stroke.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental Group
Virtual reality based therapy with augmented visuomotor feedback.
|
6 weeks, 1 session a day, 30min per sessions, of physical therapy using a VR rehabilitation gaming system (RGS) with augmented visuomotor feedback
Other Names:
|
Active Comparator: Control Group
Virtual reality based therapy without augmentation.
|
6 weeks, 1 session a day, 30min per sessions, of physical therapy using a VR rehabilitation gaming system (RGS)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The upper extremity Fugl-Meyer Assessment
Time Frame: at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up
|
change from baseline in motor function
|
at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Chedoke Arm Hand Inventory
Time Frame: at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up
|
change from baseline in functional recovery
|
at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up
|
Barthel Index
Time Frame: at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up
|
change from baseline in activities of daily living
|
at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up
|
Hamilton Scale
Time Frame: at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up
|
change from baseline in measurement of depression
|
at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Rosa Maria San Segundo Mozo, Dra., Medico Especialista en Medician Fisica y Rehabilitation, Doctora por al Universitat Rovira i Virgili de Tarragona
- Study Director: Paul F.M.J. Verschure, Prof., Director SPECS
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Robinson RG, Jorge RE. Post-Stroke Depression: A Review. Am J Psychiatry. 2016 Mar 1;173(3):221-31. doi: 10.1176/appi.ajp.2015.15030363. Epub 2015 Dec 18.
- Ramachandran VS, Rogers-Ramachandran D. Phantom limbs and neural plasticity. Arch Neurol. 2000 Mar;57(3):317-20. doi: 10.1001/archneur.57.3.317.
- de Haan RJ, Limburg M, Van der Meulen JH, Jacobs HM, Aaronson NK. Quality of life after stroke. Impact of stroke type and lesion location. Stroke. 1995 Mar;26(3):402-8. doi: 10.1161/01.str.26.3.402.
- Thomas SA, Lincoln NB. Factors relating to depression after stroke. Br J Clin Psychol. 2006 Mar;45(Pt 1):49-61. doi: 10.1348/014466505X34183.
- Ballester BR, Maier M, San Segundo Mozo RM, Castaneda V, Duff A, M J Verschure PF. Counteracting learned non-use in chronic stroke patients with reinforcement-induced movement therapy. J Neuroeng Rehabil. 2016 Aug 9;13(1):74. doi: 10.1186/s12984-016-0178-x.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2014
Primary Completion (Actual)
August 1, 2015
Study Completion (Actual)
August 1, 2015
Study Registration Dates
First Submitted
January 13, 2016
First Submitted That Met QC Criteria
January 14, 2016
First Posted (Estimate)
January 15, 2016
Study Record Updates
Last Update Posted (Estimate)
January 15, 2016
Last Update Submitted That Met QC Criteria
January 14, 2016
Last Verified
January 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEIC 53/2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemiparesis
-
University of MinnesotaCompleted
-
Pamukkale UniversityCompletedSatisfaction, Patient | Hemiparesis;Poststroke/CVATurkey
-
Pavlos KitixisActive, not recruitingHemiplegia and HemiparesisGreece
-
University of MinnesotaCompletedCongenital HemiparesisUnited States
-
UGECAM Rhône-AlpesRecruitingHemiparesis;Poststroke/CVAFrance
-
Loma Linda UniversityRecruitingHemiparesis;Poststroke/CVAUnited States
-
Reuth Rehabilitation HospitalUniversity of HaifaRecruitingHemiparesis;Poststroke/CVAIsrael
-
Taipei Medical University WanFang HospitalWithdrawnPoststroke/CVA HemiparesisTaiwan
-
NYU Langone HealthCompleted
-
University of IdahoUniversity of California, IrvineNot yet recruitingHemiparesis; Poststroke/CVA
Clinical Trials on Reinforcement-Induced Movement Therapy (RIMT)
-
Health Education Research Foundation (HERF)CompletedHemiplegic Cerebral PalsyPakistan
-
Abant Izzet Baysal UniversityCompletedSpastic Hemiplegic Cerebral PalsyTurkey
-
University Hospital of North NorwayHelse NordTerminated
-
Samsung Medical CenterCompletedCerebral Palsy Spastic HemiplegicKorea, Republic of
-
Eunice Kennedy Shriver National Institute of Child...National Institute of Neurological Disorders and Stroke (NINDS)Completed
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
University of BirminghamCompleted
-
National Institute of Neurological Disorders and...Completed
-
National Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
US Department of Veterans AffairsWithdrawnHemiplegia | Cerebrovascular Accident